Among childhood cancers, osteosarcoma holds a particular place: despite its rarity, it remains the most common primary bone cancer, followed by Ewing sarcoma, and is a very aggressive bone cancer that predominantly affects children, adolescents and young adults.
Despite decades of research and advances in treatments, therapeutic options remain challenging, particularly for patients with metastatic or relapsed tumour. Surgery and chemotherapy remain the cornerstone of treatment.
🔬 Where does osteosarcoma research stand today?
What are the current treatment options?
What do the latest figures tell us?
And what are the promising avenues being explored to improve outcomes for young patients?
For this Childhood Cancer Awareness Month, we take a closer look at osteosarcoma, from epidemiology and current treatments to the research shaping the future of care.
👉 Discover our related models >
At Atlantic Bone Screen, we are committed to supporting research in bone oncology and contributing to the development and preclinical evaluation of new therapeutic approaches.
#ChildhoodCancerAwarenessMonth #Osteosarcoma #ChildhoodCancer #BoneCancer #CancerResearch #Oncology #PreclinicalResearch #DrugDevelopment